Serum MicroRNA-137 Serves as a Novel Biomarker for Cerebral Atherosclerosis Diagnosis and Cerebrovascular Event Prediction
Open Access
- 28 May 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 78 (2) , 302-307
Abstract
MicroRNAs have been reported as biomarkers for various diseases, including cerebral atherosclerosis (AS). In this study, whether serum microRNA-137 (miR-137) could be used as a biomarker for diagnosing cerebral AS and predicting cerebrovascular event was investigated. Quantitative real-time PCR was used to measure the expression of miR-137 in serum. Logistic analysis was used to evaluate the risk factors for the occurrence of cerebral AS, and receiver operating characteristic curves were used to estimate the diagnostic value of miR-137 and other risk factors for AS occurrence. Furthermore, the prognostic value of miR-137 for patients with AS was estimated using Kaplan–Meier survival analysis and Cox regression analysis. The results indicated that serum miR-137 levels were decreased in patients with cerebral AS. The expression of miR-137 was negatively correlated with total cholesterol and low-density lipoprotein cholesterol levels in patients with cerebral AS. The levels of miR-137, total cholesterol, low-density lipoprotein cholesterol, and hypersensitivity C response protein may serve as risk factors for the occurrence of cerebral AS, and miR-137 had diagnostic value for AS screening. Cerebral AS patients with positive cerebrovascular events have low miR-137 expression. Patients with high miR-137 expression had a lower incidence of cerebrovascular adverse events (log-rank P = 0.013), and miR-137 was an independent prognostic marker for the prediction of cerebrovascular event occurrence in patients with cerebral AS. In conclusions, our findings indicate that serum miR-137 levels are decreased in patients with cerebral AS and may be a new biomarker for diagnosing cerebral AS and predicting cerebrovascular events.Keywords
This publication has 34 references indexed in Scilit:
- Plasma levels of miR-137 and miR-124 are associated with Parkinson’s disease but not with Parkinson’s disease with depressionNeurological Sciences, 2017
- Interleukin-32α Inhibits Endothelial Inflammation, Vascular Smooth Muscle Cell Activation, and Atherosclerosis by Upregulating Timp3 and Reck through suppressing microRNA-205 BiogenesisTheranostics, 2017
- MiR-137: an important player in neural development and neoplastic transformationMolecular Psychiatry, 2016
- 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular TreatmentStroke, 2015
- MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeuticsInternational Journal of Obesity, 2015
- Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cellsNature Cell Biology, 2015
- Gene and MicroRNA Profiling of Human Induced Pluripotent Stem Cell-Derived Endothelial CellsStem Cell Reviews and Reports, 2015
- MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1Nature Medicine, 2014
- Serum microRNA-21 and microRNA-221 as Potential Biomarkers for Cerebrovascular DiseaseJournal of Vascular Research, 2013
- Invited review: Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanismsInnate Immunity, 2008